Notice of Intent to Sole Source - QuidelOrtho Corporation
ID: 00546Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/4c99144953a44b59aeac0e633408b1aa/view
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) intends to award a sole source contract to QuidelOrtho Corporation for a service agreement related to the VITROS 3600 Immunodiagnostic system. This procurement includes essential services such as the provision of reagents, calibrators, controls, and consumables, as well as repairs, labor, and travel incurred during service calls, along with one annual preventive maintenance and on-site technical support. The VITROS 3600 system plays a critical role in the laboratory's operations within the Division of Viral Hepatitis, ensuring accurate diagnostic capabilities. Interested vendors with relevant expertise are encouraged to submit their capabilities and pricing information to Leyla Campbell at LCampbell@cdc.gov by February 6, 2025, at 11:00 AM ET, as the government will consider all submissions to determine if competitive procurement is warranted.

    Point(s) of Contact
    Leyla Campbell
    LCampbell@cdc.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Notice of Intent to Sole Source - QuidelOrtho Corporation
    Currently viewing
    Special Notice
    Similar Opportunities
    CDC DFWED NARST Sensititre Supplies
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    Combined Synopsis/Solicitation for InterOperability Bidco Rhapsody Software Subscription
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting quotes for a sole source contract for an annual software subscription and maintenance support for Rhapsody software from InterOperability Bidco. This procurement is critical for enhancing data interoperability within the CDC’s Enterprise Laboratory Information Management System (ELIMS) project, which aims to standardize electronic laboratory result messaging for secure data transfer among public health agencies. The contract, valued at approximately $118,226.37, will span from February 1, 2025, to January 31, 2030, with options for four additional years, and emphasizes the necessity of ongoing software updates, technical support, and compliance with healthcare standards. Interested parties can reach out to James Brown III at xvn8@cdc.gov or Eric Lyons at kpy2@cdc.gov for further information.
    Q515--Molecular analyzers, reagents and maintenance
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is initiating a sole-source acquisition with Roche Diagnostics Corp. for the provision of Microbiology Molecular Diagnostics, which includes specific molecular analyzers, reagents, and maintenance for various FDA-approved real-time PCR tests. The procurement aims to support critical healthcare services by providing qualitative and quantitative testing for conditions such as HIV, COVID-19, HPV, and hepatitis viruses, highlighting the unique capabilities of Roche Diagnostics Corp. as the sole provider for these essential diagnostic tools. Interested parties may express their interest by contacting Contract Officer James E. Boles Jr. at james.boles2@va.gov by 1:00 p.m. local time on January 27, 2025, although this notice does not constitute a request for competitive bids.
    Lateral Flow Assay (LFA) validation and manufacturing
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified sources for the validation and manufacturing of lateral flow assays (LFA) aimed at diagnosing HIV antiretroviral usage in point-of-care settings. The CDC requires an established medical device company capable of producing 25,000 lateral flow devices, which will be utilized in pre-clinical and clinical studies, with the contractor responsible for adapting the provided technical design to their production pipeline and optimizing test performance. This initiative is part of the broader effort to enhance HIV prevention and treatment strategies, emphasizing the need for rapid and cost-effective assays to monitor drug levels. Interested parties must submit their responses, including organizational details and relevant project experience, to Mark Wirtz at mag8@cdc.gov by January 31, 2025, at 12:00 p.m. EST, as this notice is for market research purposes only and does not constitute a solicitation for proposals.
    Serological Assays for the Detection and Characterization of Influenza Viruses
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract focused on serological assays for the detection and characterization of influenza viruses. The primary objectives include performing hemagglutination inhibition assays on human serum samples and developing new serology platforms that are comparable to existing methods. This initiative is crucial for enhancing influenza surveillance and vaccine effectiveness studies, addressing ongoing public health challenges. Interested parties must submit a Letter of Interest by 2:00 PM EST on February 7, 2025, and can contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further information.
    6640--FY 25 Short Term Emergency Contract Molecular Random Access Analyzer
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole-source contract for a Short Term Emergency procurement of a Molecular Random Access Analyzer, specifically the Cepheid GeneXpert Infinity Reagents and Consumables. This procurement is being conducted under FAR 13.5 Simplified Procedures for Certain Commercial Items, emphasizing the need for efficient acquisition of critical laboratory equipment. The selected vendor must demonstrate technical capability to fulfill the requirements, with responses due by January 17, 2025, at 2:00 PM Eastern Time, submitted to Contract Specialist Darrin Alexander at darrin.alexander2@va.gov. The statutory authority for this procurement is U.S.C. § 1901, and the relevant NAICS code is 334516, which pertains to Analytical Laboratory Instrument Manufacturing.
    Preventative Maintenance - EZ1 Advanced XL
    Dept Of Defense
    The Department of Defense, through the Naval Medical Research Center (NMRC), intends to award a sole source contract to Qiagen, LLC for preventative maintenance services on two EZ1 Advanced XL instruments used in their Infectious Diseases Diagnostic Laboratory. The contract will cover routine maintenance, unlimited repairs, and the provision of replacement parts for the specified equipment, ensuring compliance with the necessary servicing standards that only Qiagen can meet due to their unique qualifications and access to proprietary software. This procurement is critical for maintaining operational readiness and supporting essential diagnostic capabilities, with the service period running from April 12, 2025, to April 11, 2026. Interested vendors must be registered in the System for Award Management (SAM) and can contact Shamai Carter or Nataki Johnson Lovett for further information.
    6630--V16 Lab Chemistry and Immunochemistry CPRR BPA (VA-25-00010416)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for a Blanket Purchase Agreement (BPA) focused on Chemistry and Immunochemistry instrumentation and testing for the South Central VA Health Care Network (VISN 16). This procurement aims to standardize automated equipment across 8 medical center and 20 outpatient laboratories, ensuring compliance with the 1988 Clinical Laboratory Improvement Act and FDA approval for all reagents, while also providing operator training and 24/7 repair services. The initiative underscores the VA's commitment to enhancing laboratory capabilities through modern technology, with site visits permitted until February 28, 2025, allowing vendors to assess laboratory conditions and align their offerings with specific site requirements. Interested contractors can contact Diyonne Williams, the Contracting Officer, at Diyonne.Williams@va.gov for further information.
    Sebia Inc. Hydrasys 2 Reagents for the Department of Laboratory Medicine
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure Sebia Inc. Hydrasys 2 reagents through a sole-source contract for the Department of Laboratory Medicine. This acquisition aims to secure essential reagent kits, quality control materials, and supplies necessary for electrophoresis testing, which is critical for monitoring patients with B-cell malignancies and central nervous system diseases. The Sebia reagent kits are uniquely designed for compatibility with the existing Sebia Hydrasys 2 analyzers, ensuring high-quality patient care within the Chemistry Service. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by January 31, 2024, at 6:30 AM EST, as this is not a request for quotations.
    Preventative Maintenance and Curative Repair Beckman Coulter PT Protection Service Base plus Four Option Years
    Homeland Security, Department Of
    The Department of Homeland Security's U.S. Secret Service (USSS) is seeking qualified vendors to provide comprehensive preventative maintenance and curative repair services under the Beckman Coulter PT Protection Service Plan for three automated liquid handling systems. The procurement aims to ensure that these systems operate in compliance with International Organization for Standardization (ISO) standards, necessitating services from the specific manufacturer due to the unique nature of the equipment and parts involved. This contract, which includes a base year plus four option years, is critical for maintaining essential laboratory operations that support accurate testing on highly sensitive biological threat agents. Interested parties should contact Sabine McCorry at sabine.mccorry@usss.dhs.gov or Jade Gaston at jade.gaston@usss.dhs.gov for further details, as the solicitation number is 70US0925Q70092166 and the contract is expected to commence in June 2025.